Johnson & Johnson's Javelin IVL catheter system by Shockwave Medical successfully met primary endpoints in a clinical trial for treating peripheral artery disease (PAD). The innovative system showed safety and efficacy in managing heavily calcified, narrow blood vessels, offering a less invasive approach compared to traditional methods.